,
7 tweets,
2 min read
Read on Twitter
We hosted a confidential roundtable for experts & leaders working on the #NHS and #Brexit this week at @NuffieldTrust, thinking about how to monitor the impact of no deal and the hovering uncertainty around it. So many big issues - and some are still discussed alarmingly little!
Medical devices face a bizarre no deal landscape. DHSC say they'll need to get their products signed off by EU based agencies gov.uk/guidance/regul…. But we heard these bodies are snowed under with implementing the new EU Regulation - can they really take on so much more work?
The doubt around medicine approvals, manufacturing approvals, and so much more is making the UK a much less attractive place to invest for pharma and life sciences. Many firms are already moving supply chains and shifting key people to 🇪🇺
The loss of EHIC 📇 has received less press than the "returning expats" risk. But it matters to 🇬🇧 citizens. Many will face higher travel insurance bills. And those who require regular expensive care will be treated as uninsurable, making them unable to travel for work or holiday
Losing the mutual recognition of professional qualifications won't just make it harder for clinicians to move here. It'll mean training for those now here won't be recognised in 🇪🇺 - not an attractive prospect.
Of course the immediate impact of no deal in terms of contingency planning and stockpiling remains a concern
We have a long list of other concerns which we will be systematically tracking. Watch this space
